Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of plans to reform the immigration settlement system on the number of anaesthetists working in the health service.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

No assessment has been made of the potential impact of plans to reform the immigration settlement system on the number of anaesthetists working in the health service.

The Government has launched a consultation on proposals to reform the current settlement rules in favour of an “earned settlement” model, that considers factors such as contribution, integration, and conduct. The consultation, which runs until February 2026, seeks views on how these reforms should apply to different groups, including health and care workers.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of staff undertaking additional work in private hospitals on NHS workforce capacity.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department has made no assessment of the impact of National Health Service staff undertaking additional work in private hospitals on NHS workforce capacity.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when his Department plans to publish the review of adult gender services.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

We know that adults questioning their gender face long waiting lists for a first appointment at National Health Service adult gender services.

Dr David Levy’s Review of NHS Adult Gender Dysphoria Clinics will identify areas for improvement in relation to service quality, good practice that could be shared with other clinics, and any support that should be made available to services to assist improvement.

NHS England aims to publish the Review of Adult Gender Services in due course.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve maternity and neonatal care for people in (a) South Holland and the Deepings constituency and (b) Lincolnshire.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

Maternity and neonatal care in the South Holland and the Deepings constituency is delivered locally by Lincolnshire Local Maternity and Neonatal System. They are implementing the Continuity of Carer model of midwifery care so that women receive dedicated support from the same midwifery team throughout their pregnancy. This model will prioritise areas with higher deprivation and complex needs and aims to improve care for people in South Holland and the Deepings.

For Lincolnshire, the main provider for maternity care across the county is the United Lincolnshire Teaching Hospitals NHS Trust. The trust has taken several steps to improve maternity and neonatal care such as implementing the Continuity of Carer model and offering specialised services for women to receive dedicated support to meet specific needs, for example through the Perinatal Community Mental Health Team and Perinatal Trauma and Loss Care Service. Additionally, there are community initiatives, including a breastfeeding campaign, ongoing workforce development initiatives, such as career pathways for maternity support workers, and innovative neonatal staffing models.

The trust has also seen a reduction in women smoking at the time of delivery from 17.1% in 2020/21 to 8.4% in 2024/25, ahead of integrated care system targets.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what was the full-time equivalent vacancy rate for learning disabilities nurses across all NHS organisations in England in each of the past three years.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

NHS England published data every quarter on vacancies in National Health Service trusts. However, the data is not granular enough to identify rates for learning disability nurses.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what proportion of invoices for contracts entered into by NHS England are settled within four weeks.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

NHS England monitors the payment of invoices made within 30 days, to confirm compliance with the Better Payment Practice Code, which sets a target of 95%. In the 2024/25 financial year, 97% of invoices were paid within 30 days, with a slight reduction to 94% in the 2025/26 financial year for the six-month period to 30 September 2025, the latest period for which figures are available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the forthcoming HIV Action Plan will strengthen awareness of HIV risk among women.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The new HIV Action Plan, published on World AIDS Day on 1 December 2025, sets out how the Government will enable every level of the healthcare system to work together to engage everyone in prevention, testing, and treatment, tackle stigma, and reach our ambition to end new HIV transmissions by 2030. This includes a focus on women, as we know from the UK Health Security Agency’s latest data that they are not benefitting equally from the progress made on HIV in recent years.

Women will benefit from all of the actions in the HIV Action Plan, including improved testing and prevention services, rapid treatment, and support for those living with HIV. We will commission a new national HIV Prevention England programme backed by a total of £4.8 million of funding from April 2026 to March 2029. This programme supports communities disproportionately affected by HIV, including women, in particular black African and heterosexual women. The current programme delivers National HIV Testing Week, aimed at improving testing and increasing awareness of HIV prevention. In Testing Week 2025, heterosexual women accounted for 30% of all testers compared with 25% in 2024. We will also fund formula milk, and related sterilising equipment, for the infants of women living with HIV, thereby removing financial pressures and reducing the risk of transmission to babies.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many community diagnostic centres were open at the end of (a) 2022-23, (b) 2023-24, (c) 2024-25, and are expected to be at the end of (d) 2025-26.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The following table sets out the number of community diagnostic centres (CDCs) which had started delivering activity, namely having gone live, and which were fully operational, delivering all modalities proposed in their approved business cases, from permanent facilities, from 2022/23 to 2024/25:

Source: NHS England

Notes:

1. The table includes CDCs operating from temporary capacity while the permanent CDC build is completed.
2. For 2025/26, the numbers include CDC sites which are anticipated to be fully operational by the end of March 2026 based on current delivery plans.

The Elective Reform Plan sets out that the Government will deliver additional CDC capacity in 2025/26 by expanding several existing CDCs and building up to five new CDCs. The locations of both new and expanded CDC schemes will be confirmed in due course. This is funded as part of £600 million of capital investment for diagnostics in 2025/26, which my rt. Hon. Friend, the Chancellor of the Exchequer, set out in her June 2025 statement.

The plan also commits to opening more CDCs 12 hours per day, seven days a week, meaning patients can access vital diagnostic tests around busy working lives. Upon entering office in July 2024, 63 CDCs were offering at least one diagnostic service out of hours, available to patients 12 hours a day, seven days a week.

The latest position at the end of November 2025 is that 101 CDCs are offering at least one service to this standard, an increase of 38 from July 2024. By the end of March 2026, this number is currently planned to increase to 116.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care what estimate he has made of adult COVID-19 and influenza vaccination uptake in 2024–25; and what steps his Department is taking to strengthen communication of vaccine value to the public in response to hesitancy.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The UK Health Security Agency (UKHSA) publishes annual reports on seasonal flu vaccine uptake for England. COVID-19 vaccination uptake figures are published regularly during the spring and winter campaigns, as part of the national flu and COVID-19 surveillance report, and are available at the following link:

https://www.gov.uk/government/collections/weekly-national-flu-reports

The adult groups which the vaccine is offered to includes those over 65 years of age, clinical risk groups, pregnant women, and frontline healthcare workers. Compared to the previous 2023 to 2024 season, uptake was higher in pregnant women. Comparisons cannot be made to the previous season for other adult groups, due to changes in the timing of programme implementation.

The Department works with the UKHSA and NHS England to deliver national communications supporting vaccine uptake. The UKHSA undertakes research, assessing public confidence, barriers, and motivators to vaccination uptake, and develops strategies and messaging tailored to different audiences.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of the Taskforce for Lung Health briefing entitled A Modern Service Framework for Respiratory campaign, published on 18 November 2025.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is aware of the taskforce for Lung Health’s report calling for a Modern Service Framework for Respiratory Health, including the impact of respiratory conditions on mortality rates, emergency admissions, inequalities, and productivity.

Modern service frameworks will define an aspirational, long-term outcome goal for a major condition and then identify the best evidenced interventions and the support for delivery. Early priorities will include cardiovascular disease, severe mental illness, and the first ever service framework for frailty and dementia.

The Government will consider other long-term conditions for future waves of modern service frameworks, including respiratory conditions. The criteria for determining other conditions for future modern service frameworks will be based on where there is potential for rapid and significant improvements in quality of care and productivity.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of reviewing the clarity of escalation pathways for parents of children with complex medical needs.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Integrated care boards (ICBs) in England are responsible for commissioning services to meet the health needs of their local population. ICBs are expected to follow guidance from the National Institute for Health and Care Excellence (NICE). In 2022, NICE published guidance on Disabled children and young people up to 25 with severe complex needs. This is available at the following link:

https://www.nice.org.uk/guidance/ng213/chapter/Recommendations-on-service-organisation-integration-and-commissioning

NHS England is rolling out Martha’s Rule in acute provider sites, which gives in-patients and their families or carers who are concerned about physiological deterioration the ability to initiate a rapid review of their case from someone outside of their immediate care team. When requested, this rapid review will inform whether any new or additional action needs to be taken to ensure patients receive the most appropriate care and treatment, which may include escalation.

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they considered the impact of ongoing COVID-19 circulation on shielding immunocompromised patients as part of Exercise Pegasus.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The pandemic scenario designed in Exercise PEGASUS and given to participants was based on the emergence and spread of a novel pathogen and provided a realistic representation of its impact on the United Kingdom’s population, including those with existing conditions. The exercise included the circulation of existing pathogens such as COVID-19. Focus groups and surveys were carried out after each core exercise day to test the public reaction to the decisions taken by officials and ministers, and respondents were drawn from a broad cross-section of society, including those who were immunocompromised.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he Department is taking to improve integration between NHS services and social care provision in West Dorset.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Department is committed to improving integration between health and social care services nationally and locally. Our vision for Neighbourhood Health will see local government and the National Health Service working more closely together, with a revitalised role for Health and Wellbeing Boards and reform of the Better Care Fund (BCF).

Through the BCF, approximately £9 billion is being invested in 2025/26 to enable NHS bodies and local authorities to pool budgets and deliver joined-up care. This includes setting shared goals to reduce delayed discharges, avoid unnecessary hospital admissions, and support people to live independently at home. Dorset has also received additional support from expert advisors working on behalf of NHS England and the Department.

Whilst no specific assessment has been made of the impact of closer NHS-social care integration on reducing hospital discharge delays in West Dorset, local Health and Wellbeing Boards are required to agree plans under the BCF framework to provide timely and coordinated support for people with complex needs. These plans prioritise effective discharge from hospital and recovery in the community.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 November 2025 to Question 92292, what assessment his Department has made of the potential impact of the requirement for pre-visit notifications on the uptake of free eye health screening on people experiencing long term homelessness.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department holds information on the number of resident doctors who, whilst on strike, work for another trust.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessments his department has made of the predicted total cost of UK-US pharmaceutical deal on the NHS budget.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve integration between social care and NHS services nationally.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Department is committed to improving integration between health and social care services nationally and locally. Our vision for Neighbourhood Health will see local government and the National Health Service working more closely together, with a revitalised role for Health and Wellbeing Boards and reform of the Better Care Fund (BCF).

Through the BCF, approximately £9 billion is being invested in 2025/26 to enable NHS bodies and local authorities to pool budgets and deliver joined-up care. This includes setting shared goals to reduce delayed discharges, avoid unnecessary hospital admissions, and support people to live independently at home. Dorset has also received additional support from expert advisors working on behalf of NHS England and the Department.

Whilst no specific assessment has been made of the impact of closer NHS-social care integration on reducing hospital discharge delays in West Dorset, local Health and Wellbeing Boards are required to agree plans under the BCF framework to provide timely and coordinated support for people with complex needs. These plans prioritise effective discharge from hospital and recovery in the community.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of closer NHS–social care integration on reducing hospital discharge delays in West Dorset.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Department is committed to improving integration between health and social care services nationally and locally. Our vision for Neighbourhood Health will see local government and the National Health Service working more closely together, with a revitalised role for Health and Wellbeing Boards and reform of the Better Care Fund (BCF).

Through the BCF, approximately £9 billion is being invested in 2025/26 to enable NHS bodies and local authorities to pool budgets and deliver joined-up care. This includes setting shared goals to reduce delayed discharges, avoid unnecessary hospital admissions, and support people to live independently at home. Dorset has also received additional support from expert advisors working on behalf of NHS England and the Department.

Whilst no specific assessment has been made of the impact of closer NHS-social care integration on reducing hospital discharge delays in West Dorset, local Health and Wellbeing Boards are required to agree plans under the BCF framework to provide timely and coordinated support for people with complex needs. These plans prioritise effective discharge from hospital and recovery in the community.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of allowing appropriately skilled professionals using a competency-based framework to undertake Initial Health Assessments.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Local authorities are responsible for making sure a health assessment of physical, emotional and mental health needs is carried out for every child they look after, regardless of where that child lives. Integrated care boards (ICBs) commission a health provider to undertake initial health assessments (IHAs). The service specification for this service is aligned to the current Children Act 1989 regulations.

The regulations for health assessments are set out in the Care Planning, Placement and Case Review (England) Regulations 2010, the Children Act 1989 guidance and regulations colume 2: care planning, placement and case review and supported within the statutory guidance Promoting the health and wellbeing of looked-after children.

Regulation 7(3) of the Care Planning, Placement and Case Review (England) Regulations 2010 states that IHAs are required to be undertaken within twenty days of a child coming into the care of the local authority. The current regulations for the Children Act 1989 state that the IHA should be undertaken by a registered medical practitioner.

This is different to a review health assessment, which may be carried out by a registered medical practitioner, or by a registered nurse or registered midwife, under the supervision of a registered medical practitioner, as stated in regulation 7(3).

No assessment has been made on the potential merits of allowing additional appropriately skilled professionals using a competency-based framework to undertake IHAs.

If IHAs are not happening on time, ICBs are the first line of statutory safeguarding assurance, which includes identifying early warning signs and responding to risks at local levels. NHS England, through ICBs, also undertake annual checks on how safeguarding, and other statutory commitments, are working in practice and across the system. NHS England is working with ICBs to improve the timeliness of IHAs and review health assessments.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of progress against the commitment in the NHS 10 Year Plan for Health to launch a new large-scale study to sequence the genomes of 150,000 adults and assess how genomics can be used in routine preventive care.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The 10-Year Health Plan for England committed to launching a large-scale study, led by Genomics England, to sequence 150,000 adult genomes and assess how genomics can support routine preventive care. Work is now underway to design the study, develop scientific and clinical methodologies, and establish governance in line with major programme standards. Genomics England has commissioned a structured literature review and launched the Genomics, Healthcare and You engagement programme to understand the diverse public and professional perspectives on pre-emptive, preventative population healthcare, while building trust and transparency. This engagement will run through 2025/26, with interim findings shaping study design and recruitment strategies which will be developed in 2026/27. Subject to ethics approval, the recruitment and sequencing of participants is expected to begin from 2027.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that online healthcare provision reflects the needs of diverse modern families.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government will establish an “online hospital”, NHS Online, which will give people on certain pathways the choice of getting the specialist care they need from their home. It will connect patients with clinicians across the country through secure, online appointments accessed through the NHS App.

Before NHS Online goes live, the National Health Service will learn from existing research on patient experience of online care over the last five years and build it into the programme as it develops, with a commitment to patient partnership in design and delivery. Inclusive service design is a key priority to ensure people continue to have greater access, choice, and control over their care.

Digital health tools will be part of a wider offering that includes traditional face-to-face support with appropriate help for people who struggle to access digital services. Digital inclusion is a key priority for the NHS as it will support the shift from ‘analogue to digital’. It is one of the five national NHS England Health Inequalities Strategic Priorities, and they published a Digital Healthcare Framework which has guided the integrated care boards’ approach.

To improve digital awareness and access, the NHS App team are working with through the National Health Literacy Partnership to provide an NHS App support offer to public libraries in England.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve a) awareness of and b) access to online health care services among families and carers.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government will establish an “online hospital”, NHS Online, which will give people on certain pathways the choice of getting the specialist care they need from their home. It will connect patients with clinicians across the country through secure, online appointments accessed through the NHS App.

Before NHS Online goes live, the National Health Service will learn from existing research on patient experience of online care over the last five years and build it into the programme as it develops, with a commitment to patient partnership in design and delivery. Inclusive service design is a key priority to ensure people continue to have greater access, choice, and control over their care.

Digital health tools will be part of a wider offering that includes traditional face-to-face support with appropriate help for people who struggle to access digital services. Digital inclusion is a key priority for the NHS as it will support the shift from ‘analogue to digital’. It is one of the five national NHS England Health Inequalities Strategic Priorities, and they published a Digital Healthcare Framework which has guided the integrated care boards’ approach.

To improve digital awareness and access, the NHS App team are working with through the National Health Literacy Partnership to provide an NHS App support offer to public libraries in England.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure NHS Online is accessible to people with limited a) digital skills and b) internet access.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government will establish an “online hospital”, NHS Online, which will give people on certain pathways the choice of getting the specialist care they need from their home. It will connect patients with clinicians across the country through secure, online appointments accessed through the NHS App.

Before NHS Online goes live, the National Health Service will learn from existing research on patient experience of online care over the last five years and build it into the programme as it develops, with a commitment to patient partnership in design and delivery. Inclusive service design is a key priority to ensure people continue to have greater access, choice, and control over their care.

Digital health tools will be part of a wider offering that includes traditional face-to-face support with appropriate help for people who struggle to access digital services. Digital inclusion is a key priority for the NHS as it will support the shift from ‘analogue to digital’. It is one of the five national NHS England Health Inequalities Strategic Priorities, and they published a Digital Healthcare Framework which has guided the integrated care boards’ approach.

To improve digital awareness and access, the NHS App team are working with through the National Health Literacy Partnership to provide an NHS App support offer to public libraries in England.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what timeframes his Department will set out to implement the findings of Exercise Pegasus.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Live participation in Exercise PEGASUS has now concluded, although a fourth phase, centred around recovery, is planned to be exercised in 2026. A published post-exercise report will include learning and findings from this and all preceding phases and this will be delivered in due course following detailed evaluation. The United Kingdom uses a Lead Government Department model to cover all phases of emergency planning, response, recovery, and risk assessment. Ministers within the Department, as the Lead Government Department for a pandemic response, will continue to actively consider the implementation of the findings from Exercise PEGASUS.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, which minister will be responsible for implementing the findings from Exercise Pegasus.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Live participation in Exercise PEGASUS has now concluded, although a fourth phase, centred around recovery, is planned to be exercised in 2026. A published post-exercise report will include learning and findings from this and all preceding phases and this will be delivered in due course following detailed evaluation. The United Kingdom uses a Lead Government Department model to cover all phases of emergency planning, response, recovery, and risk assessment. Ministers within the Department, as the Lead Government Department for a pandemic response, will continue to actively consider the implementation of the findings from Exercise PEGASUS.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when his Department will publish the report findings from Exercise Pegasus.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Live participation in Exercise PEGASUS has now concluded, although a fourth phase, centred around recovery, is planned to be exercised in 2026. A published post-exercise report will include learning and findings from this and all preceding phases and this will be delivered in due course following detailed evaluation. The United Kingdom uses a Lead Government Department model to cover all phases of emergency planning, response, recovery, and risk assessment. Ministers within the Department, as the Lead Government Department for a pandemic response, will continue to actively consider the implementation of the findings from Exercise PEGASUS.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to meet their manifesto commitment to provide open-access mental health services for children and young people in every community; and what is the expected timeline for full implementation.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is establishing Young Futures Hubs to bring together services that improve access to opportunities and support for children and young people in community settings, promoting positive outcomes and enabling them to thrive.

Since 2024/25, 24 Early Support Hubs received top-up funding of £8 million to expand their early intervention and prevention support for children and young people's mental health and to take part in an ongoing evaluation of these services.

The evaluation of the Early Support Hubs project will make a significant contribution to the design and implementation of Young Futures Hubs, ensuring that services continue to evolve to meet the needs of young people.

Young Futures Hubs will provide early wellbeing support and ensure there is no wrong front door for children and young people, including those aged 18 to 25 years old, seeking mental health help. Hubs will direct individuals to National Health Service mental health services where more specialist support is required.

The hubs will be designed in partnership with local areas, drawing on local understanding of need and the landscape of existing services. The Government aims to establish 50 hubs over the next four years in the places where they will have the greatest impact. The first eight Young Futures Hubs will launch by the end of this financial year, supported by £2 million of investment.

Also, we will accelerate the rollout of Mental Health Support Teams in schools and colleges to reach full national coverage by 2029.

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether the Physician Associate/Assistant Preceptorship Programme for primary care is open to newly qualified physician associates.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Following the publication of the Leng Review recommendations on 16 July 2025, NHS England has updated the eligibility criteria for the preceptorship in primary care for physician assistants (PAs), which are still legally known as physician associates.

In line with the recommendation that newly qualified PAs should gain at least two years of experience in secondary care, the scheme is only open to qualified PAs already employed in primary care, as of 16 July 2025, who have not undertaken a PA preceptorship.

NHS England has published a frequently asked questions document, a copy of which is attached, to provide further information and guidance on the implementation of The Leng Review. This confirms that the scheme will be honoured and continue for those employers and PAs currently participating in the programme this financial year.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the likelihood of the NHS meeting its 2 per cent productivity growth target.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government remains committed to the 2% National Health Service productivity growth target, as set out in the Spending Review and Autumn Statement. This ambition is central to ensuring that the NHS can sustainably meet rising demand.

Recent data indicates good progress. NHS England’s latest estimates show productivity growth of 2.4% between April to July 2025, building on a 2.7% increase in 2024/25. While challenges remain, such as industrial action, these figures, which focus on the acute sector where data quality is strongest, suggest the NHS is on track to meet its productivity commitments.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to ensure that more research and clinical trials are undertaken into the causes and treatment of brain cancer.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department delivers research via the National Institute for Health and Care Research (NIHR) and is committed to furthering our investment and driving scientific advancements in research into the causes and treatment of brain tumours. Between 2018/19 and 2023/24, the NIHR invested £11.8 million, and UK Research and Innovation invested £46.8 million in this area.

During the same period, the NIHR’s wider investments of approximately £37.5 million in research infrastructure and the research workforce have enabled the delivery of an additional 261 brain tumour research studies, allowing over 11,400 more people to participate in brain tumour research. NIHR infrastructure provides world-class research expertise, specialist facilities, a research delivery workforce, and support services to enable and deliver research across the National Health Service and wider health and care system.

In September 2024 the NIHR launched a package of support to deliver a step-change in brain cancer research by establishing a national NIHR Brain Tumour Research Consortium to bring together researchers from different disciplines to drive scientific advancements in how to prevent, detect, manage, and treat brain tumours. We will announce funding decisions this year, including a dedicated funding call for research into care, support, and rehabilitation for people living with brain tumours, as well as the Allied Health Professionals Brain Tumour Research Fellowship programme, a partnership with the Tessa Jowell Brain Cancer Mission.

These funding calls mark an innovative collaboration between charities, research funders, and the Government to listen and consult with the brain tumour community to increase and accelerate research into brain tumours. The NIHR continues to welcome funding applications for research into any aspect of human health and care, including brain tumours.

To improve clinical trial access for brain tumour patients, the 10-Year Health Plan outlines how the Department will fast-track clinical trial set-up time to 150 days by March 2026. We are building capacity to deliver clinical trials through 21 new Commercial Research Delivery Centres across the United Kingdom, and we also support the Rare Cancers Private Members Bill. Once implemented, this bill will make it easier for brain tumour patients to be recruited to clinical trials.

Additionally, the National Cancer Plan will include further details on how we will improve outcomes for cancer patients, as well as speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, including access to genetic testing to support treatment.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to include a) Ehlers-Danlos syndromes and b) hypermobility spectrum disorders in plans to improve the delivery of treatment for people with chronic illnesses.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The National Health Service recognises that people with chronic conditions, including Ehlers–Danlos syndrome (EDS) and hypermobility spectrum disorders (HSD), require personalised, coordinated care. EDS comprises 13 rare inherited connective-tissue disorders affecting multiple body systems. Hypermobile EDS (hEDS) is the most common sub-type and, along with HSD, is frequently associated with chronic, high-impact musculoskeletal pain. Patients may be managed across primary care, community services, and secondary care services, and diagnosis and management of the most complex cases is supported by the nationally commissioned diagnostic centres in London and Sheffield.

The Getting It Right First Time (GIRFT) Rheumatology report published in July 2021 highlighted that non-inflammatory musculoskeletal conditions, such as hypermobility-related chronic pain, benefit most from multidisciplinary, personalised pain-management strategies delivered in primary and community care, rather than routine referral to rheumatology. The GIRFT Chronic Pain workstream, introduced in 2025, is reviewing service delivery across all care settings to improve access, equity, and outcomes for patients with persistent pain.

These initiatives align with wider NHS and Government plans to improve care for people with chronic illnesses by promoting integrated, proactive, and person-centred management, including multidisciplinary support in primary care networks, enhanced specialist input where needed, and better access to evidence-based interventions. For people with hEDS and HSD, this means earlier recognition, holistic management of chronic pain, and coordinated pathways that reduce unnecessary specialist referrals while ensuring complex cases are referred to appropriate tertiary services.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of (a) the Government’s plans to bring NHS England into the Department of Health and Social Care and (b) the planned 50% reduction in integrated care board staffing on those boards’ capacity to safeguard children, including their effective participation in multi-agency child protection teams proposed in the Children’s Wellbeing and Schools Bill.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government will publish an impact assessment of its plan to bring NHS England into the Department alongside the primary legislation to enact this reform. We do not expect the integration to have an impact on the capacity of integrated care boards (ICBs) to safeguard children, as the existing safeguarding functions of ICBs will be retained.

To ensure ICBs maintain effective safeguarding functions throughout the reform, NHS England has shared best practice on safeguarding with ICBs earlier this year. In November 2025, NHS England also published a strategic commissioning framework for ICBs with a focus on collaboration with local government and wider system partners.

Safeguarding partners, including health, have a legal duty to work together to safeguard and promote children’s welfare, including through the proposed Multi Agency Child Protection Teams. There is no intention to change this duty through the ICB reform.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to Recommendations 6 and 7 of Module 1 of the UK Covid 19 Inquiry, what steps he is taking to (1) gather and (2) publish findings, lessons and recommendations within the recommended 3 month window; and whether he will publish an action plan based on the findings from Exercise Pegasus.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Live participation in Exercise PEGASUS has now concluded, although a fourth phase, centred around recovery, is planned to be exercised in 2026. A published post-exercise report will include learning and findings from this and all preceding phases and this will be delivered in due course following detailed evaluation. The United Kingdom uses a Lead Government Department model to cover all phases of emergency planning, response, recovery, and risk assessment. Ministers within the Department, as the Lead Government Department for a pandemic response, will continue to actively consider the implementation of the findings from Exercise PEGASUS.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many of the neighbourhood health centres announced in the autumn budget 2025 will be based in Lincolnshire.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

At the Autumn Budget, we announced our commitment to deliver 250 Neighbourhood Health Centres (NHCs) through the NHS Neighbourhood Rebuild Programme. This will deliver NHCs through a mixture of refurbishments to expand and improve sites over the next three years and new-build sites opening in the medium term. The first 120 NHCs are due to be operational by 2030 and will be delivered through public private partnerships and public capital.

Nationwide coverage will take time, but we will start in the areas of greatest need where healthy life expectancy is lowest, including rural towns and communities with higher deprivation levels, targeting places where healthy life expectancy is lowest and delivering healthcare closer to home for those that need it the most.

Integrated care boards (ICBs) are responsible for commissioning, which includes planning, securing, and monitoring, general practice services within their health systems through delegated responsibility from NHS England. Both ICBs and local health systems will be responsible for determining the most appropriate locations for Neighbourhood Health Centres.

We have also launched wave 1 of the National Neighbourhood Health Implementation Programme (NNHIP) in 43 areas across England, including North East Lincolnshire. The NNHIP is supporting systems across the country in driving innovation and integration at a local level to improve the care they provide to their communities.

We expect neighbourhood teams and services to be designed in a way that reflects the specific needs of local populations. While the focus on personalised, coordinated care will be consistent, that will mean the service will look different in rural communities such as Lincolnshire.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what specific measures they are taking to ensure young people aged 18-25 can access appropriate mental health support in the community.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department is establishing Young Futures Hubs to bring together services that improve access to opportunities and support for children and young people in community settings, promoting positive outcomes and enabling them to thrive.

Since 2024/25, 24 Early Support Hubs received top-up funding of £8 million to expand their early intervention and prevention support for children and young people's mental health and to take part in an ongoing evaluation of these services.

The evaluation of the Early Support Hubs project will make a significant contribution to the design and implementation of Young Futures Hubs, ensuring that services continue to evolve to meet the needs of young people.

Young Futures Hubs will provide early wellbeing support and ensure there is no wrong front door for children and young people, including those aged 18 to 25 years old, seeking mental health help. Hubs will direct individuals to National Health Service mental health services where more specialist support is required.

The hubs will be designed in partnership with local areas, drawing on local understanding of need and the landscape of existing services. The Government aims to establish 50 hubs over the next four years in the places where they will have the greatest impact. The first eight Young Futures Hubs will launch by the end of this financial year, supported by £2 million of investment.

Also, we will accelerate the rollout of Mental Health Support Teams in schools and colleges to reach full national coverage by 2029.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to extend the powers for local authorities and their associated enforcement agencies to regulate non-surgical cosmetic procedures and what plans they have to introduce legislation to implement a mandatory licensing scheme in England.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to addressing longstanding concerns around the safety of the cosmetics sector. On 7 August we announced our plans to introduce further regulation in this space.

In the first instance, the Government will prioritise the introduction of legal restrictions to ensure that cosmetic procedures that are deemed to pose the highest level of risk to the public, such as the liquid Brazilian butt lift, are classed as Care Quality Commission (CQC) regulated activities. The new restrictions will mean that these procedures will only be permitted to be performed by suitably qualified regulated healthcare professionals, working for providers who are registered with the CQC. We are working with stakeholders to develop our plans in this space and intend to consult on proposals for restrictions around the performance of the highest risk procedures in spring 2026.

The Government has also committed to legislating to introduce a licensing scheme for non-surgical cosmetic procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. We are taking forward work to determine which procedures will be included within the local authority licensing scheme and what requirements will have to be met in order to be granted a licence. The proposals will be developed through further stakeholder engagement and public consultation before being taken forward through secondary legislation and the requisite parliamentary processes.

Further details of the Government’s commitments are available in the Government’s response to the 2023 consultation on the GOV.UK website.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to introduce a mandated national standard of education and training for those who practise in the aesthetics sector and what plans does the Government have for the implementation of statutory regulation for the sector.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to addressing longstanding concerns around the safety of the cosmetics sector. On 7 August we announced our plans to introduce further regulation in this space.

In the first instance, the Government will prioritise the introduction of legal restrictions to ensure that cosmetic procedures that are deemed to pose the highest level of risk to the public, such as the liquid Brazilian butt lift, are classed as Care Quality Commission (CQC) regulated activities. The new restrictions will mean that these procedures will only be permitted to be performed by suitably qualified regulated healthcare professionals, working for providers who are registered with the CQC. We are working with stakeholders to develop our plans in this space and intend to consult on proposals for restrictions around the performance of the highest risk procedures in spring 2026.

The Government has also committed to legislating to introduce a licensing scheme for non-surgical cosmetic procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. We are taking forward work to determine which procedures will be included within the local authority licensing scheme and what requirements will have to be met in order to be granted a licence. The proposals will be developed through further stakeholder engagement and public consultation before being taken forward through secondary legislation and the requisite parliamentary processes.

Further details of the Government’s commitments are available in the Government’s response to the 2023 consultation on the GOV.UK website.

Question to the Department of Health and Social Care:

To ask His Majesty's Government when they plan to publish a timeline for the design and implementation of a national licensing scheme for non-surgical cosmetic procedures, including injectable toxins and dermal fillers.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is committed to addressing longstanding concerns around the safety of the cosmetics sector. On 7 August we announced our plans to introduce further regulation in this space.

In the first instance, the Government will prioritise the introduction of legal restrictions to ensure that cosmetic procedures that are deemed to pose the highest level of risk to the public, such as the liquid Brazilian butt lift, are classed as Care Quality Commission (CQC) regulated activities. The new restrictions will mean that these procedures will only be permitted to be performed by suitably qualified regulated healthcare professionals, working for providers who are registered with the CQC. We are working with stakeholders to develop our plans in this space and intend to consult on proposals for restrictions around the performance of the highest risk procedures in spring 2026.

The Government has also committed to legislating to introduce a licensing scheme for non-surgical cosmetic procedures through powers granted through the Health and Care Act 2022. Under this scheme, which will be operated by local authorities, practitioners will be required to obtain a licence to perform specified cosmetic procedures, and the premises from which they operate will also need to be licensed. We are taking forward work to determine which procedures will be included within the local authority licensing scheme and what requirements will have to be met in order to be granted a licence. The proposals will be developed through further stakeholder engagement and public consultation before being taken forward through secondary legislation and the requisite parliamentary processes.

Further details of the Government’s commitments are available in the Government’s response to the 2023 consultation on the GOV.UK website.

Question to the Department of Health and Social Care:

To ask His Majesty's Government how many full-time equivalent learning disabilities nurses were employed across all NHS organisations in England in each of the past three years.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

NHS England publishes monthly NHS Hospital and Community Health Service Workforce Statistics for England. These include staff working for hospital trusts and core organisations but excludes staff working for other providers such as in primary care, general practice, or social care. This data is drawn from the Electronic Staff Record, the human resources system for the National Health Service. The following table shows the number of full-time equivalent learning disability nurses in hospital trusts and core organisations across England as of 30 September for each of the years 2022 to 2025:

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of (a) the effectiveness of the monitoring of early foetal development in patients by trusts and (b) trends in the level of variations in that monitoring by those trusts.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make it his policy to expand BRCA testing to men, including those with male relatives of confirmed BRCA carriers.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to develop a modern service framework for respiratory health.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Modern service frameworks will define an aspirational, long-term outcome goal for a major condition and then identify the best evidenced interventions and the support for delivery. Early priorities will include cardiovascular disease, severe mental illness, and the first ever service framework for frailty and dementia.

The Government will consider other long-term conditions for future waves of modern service frameworks, including respiratory conditions. The criteria for determining other conditions for future modern service frameworks will be based on where there is potential for rapid and significant improvements in quality of care and productivity.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many and what proportion of patients waited more than (a) 12, (b) 24, (c) 48 and (d) 60 hours at A&E at Lincoln County Hospital in the last 12 months.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how he plans to fund the UK-US pharmaceutical deal.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether the recent decision to pass details from a government-commissioned opinion poll of resident doctors by Savanta to The Times newspaper was made by ministers or by civil servants.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government holds contracts with polling companies to conduct research on public opinion. Savanta is a member of the British Polling Council and as such is required to abide by its rules. The results of polling by Savanta of resident doctors are published online and can be found on their website.

Question to the Department of Health and Social Care:

To ask His Majesty's Government why the decision was made to pass the results of question 10 of the government-commissioned opinion poll of resident doctors by Savanta to The Times, while withholding the results of question 9.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government holds contracts with polling companies to conduct research on public opinion. Savanta is a member of the British Polling Council and as such is required to abide by its rules. The results of polling by Savanta of resident doctors are published online and can be found on their website.

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether Exercise Pegasus assessed the adequacy of government communication with clinically vulnerable populations during health emergencies.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

Exercise PEGASUS rigorously tested communications capabilities, which included testing communications from Government and public health bodies to clinically vulnerable populations. Officials used behavioural science insights to segment audiences based on a variety of factors, and developed tailored, accessible messaging for these groups. This will be considered in the evaluation of the exercise.

Organisations who advocate for clinically vulnerable patient groups were also engaged through focus groups, which sought perspectives on the outcomes of the exercise. These insights will contribute towards the exercise report.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve (a) monitoring of the medicine supply chain and (b) verification of medicines.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The resilience of the United Kingdom’s supply chains is a key priority, and the Department and NHS England are committed to helping to build long term supply chain resilience for medicines. We are continually learning and seeking to improve the way we work to both manage and help prevent supply issues and avoid shortages. The Department, working closely with NHS England, is taking forward a range of actions to improve our ability to mitigate and manage shortages and strengthen our resilience. As part of that work, we continue to engage with industry, the Medicines and Healthcare products Regulatory Agency and other colleagues across the supply chain as we progress work to co-design and deliver solutions. However, medicine shortages are a complex and global issue and everyone in the supply chain has a role to play in addressing them, as any action will require a collaborative approach.

We proactively monitor of supply and demand where there are particular concerns or threats to supply and as part of the management of live issues.

Potential disruption can also be identified early through targeted monitoring around specific events or risks. For example, growing demand and challenges in forecasting disease rates during winter, combined with broader strains on healthcare, can put extra pressure on already stressed supply chains. For the past two winters, the Department and NHS England set up a winter monitoring group to proactively monitor, analyse, and assess demand trends for a specified subset of medicines most likely to be needed. These medicines were identified by analysing historical demand data, together with known supply constraints and clinical criticality.

While manufacturers are not mandated to put verification barcodes on products, they are able to do so. This can help identify medicines accurately, automate storage and retrieval, verify expiry dates and batch numbers, and ensure the right product reaches the right patient, including automated dispensing or specific checks of the products due to be administered on hospital wards.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish the annual figures for payments made to each of NHS Resolution's panel law firms since the current legal framework came into effect in March 2022; and, in each case, what proportion of these payments were attributable to (a) medical negligence claims and (b) other claims.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

NHS Resolution (NHSR) manages clinical negligence and other claims against the National Health Service in England. The information to the question requested is not published by NHSR on its website. NHSR does publish annual statistics, however, which are available at the following link:

https://resolution.nhs.uk/resources/annual-statistics/

The second table in the document attached also shows the total spend for NHSR on NHS legal costs.

NHSR has also responded to individual enquiries under Freedom of Information for payments made to panel law firms, which can be found on its website at the following link:

https://resolution.nhs.uk/?s=FOI+Panel+firm+costs

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of DCVax-L following its trial at King’s College Hospital.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department has made no assessment of the potential merits of DCVax-L following its trial at King’s College Hospital.

Northwest Biotherapeutics has submitted a Marketing Authorisation Application to the Medicines and Healthcare products Regulatory Agency (MHRA) for DCVax-L, an immunotherapy for glioblastoma. The MHRA is unable to comment on applications during the process of review, but the MHRA can confirm that this application is not affected by any historical backlogs and is assessing all applications rapidly for safety, quality, and efficacy.

The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether all new licensed medicines should be routinely funded by the NHS based on an assessment of clinical and cost effectiveness. NICE aims wherever possible to issue recommendations on new medicines close to the time of licensing. The NHS is legally required to fund medicines recommended by NICE, normally within three months of the publication of final guidance. NICE is in discussions with the manufacturer of DCVax-L, Northwest Biotherapeutics, about a potential appraisal subject to licensing.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what mechanisms exist to support waste-reduction trials with NHS trusts.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department and NHS England are always looking at ways of reducing waste and increasing efficiency. NHS England has had many discussions with National Health Service trusts on the reduction, elimination, and reuse of single-use polypropylene curtains, and have published best practice with regards to safe and sustainable management of healthcare waste.

In addition, the Department has published the Design for Life Roadmap, a new strategy to transition away from all avoidable single-use medical technology (medtech) products towards a functioning circular system by 2045. This means designing, procuring, and processing medtech products in a way that maximises reuse, remanufacture, and recycling, thus preserving their value for as long as possible. The document sets out a plan of 30 actions to deliver the 2045 vision, which involve:

• driving positive behavioural change;
• exploring new commercial incentives to provide circular medtech, including value-based procurement;
• creating new standards to enable innovative products and services;
• planning the decontamination and recycling infrastructure of the future; and
• establishing new collaborations to accelerate the emergence of transformative science.

The Design for Life Roadmap is available at the following link:

https://www.gov.uk/government/publications/design-for-life-roadmap

As part of its work, the Design for Life programme maintains a list of products where circular alternatives are already available, and, for those with the highest potential benefits, explores means to accelerate adoption across the NHS. Ward curtains are on this product list, where a dedicated group, including procurement and clinical experts, are working to explore how the adoption of reusable versions can be supported.

With regards to trials, the Design for Life programme has commissioned several pilots within NHS trusts to explore safe transitions from single-use to reusables, where the results have been published and cascaded among the NHS community. Furthermore, NHS England has developed and deployed an Innovation Portal to help document, evaluate, test, and deploy innovations in waste management across the NHS in England.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with NHS trusts on the potential reuse of polypropylene ward curtains.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department and NHS England are always looking at ways of reducing waste and increasing efficiency. NHS England has had many discussions with National Health Service trusts on the reduction, elimination, and reuse of single-use polypropylene curtains, and have published best practice with regards to safe and sustainable management of healthcare waste.

In addition, the Department has published the Design for Life Roadmap, a new strategy to transition away from all avoidable single-use medical technology (medtech) products towards a functioning circular system by 2045. This means designing, procuring, and processing medtech products in a way that maximises reuse, remanufacture, and recycling, thus preserving their value for as long as possible. The document sets out a plan of 30 actions to deliver the 2045 vision, which involve:

• driving positive behavioural change;
• exploring new commercial incentives to provide circular medtech, including value-based procurement;
• creating new standards to enable innovative products and services;
• planning the decontamination and recycling infrastructure of the future; and
• establishing new collaborations to accelerate the emergence of transformative science.

The Design for Life Roadmap is available at the following link:

https://www.gov.uk/government/publications/design-for-life-roadmap

As part of its work, the Design for Life programme maintains a list of products where circular alternatives are already available, and, for those with the highest potential benefits, explores means to accelerate adoption across the NHS. Ward curtains are on this product list, where a dedicated group, including procurement and clinical experts, are working to explore how the adoption of reusable versions can be supported.

With regards to trials, the Design for Life programme has commissioned several pilots within NHS trusts to explore safe transitions from single-use to reusables, where the results have been published and cascaded among the NHS community. Furthermore, NHS England has developed and deployed an Innovation Portal to help document, evaluate, test, and deploy innovations in waste management across the NHS in England.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce levels of NHS waste.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department and NHS England are always looking at ways of reducing waste and increasing efficiency. NHS England has had many discussions with National Health Service trusts on the reduction, elimination, and reuse of single-use polypropylene curtains, and have published best practice with regards to safe and sustainable management of healthcare waste.

In addition, the Department has published the Design for Life Roadmap, a new strategy to transition away from all avoidable single-use medical technology (medtech) products towards a functioning circular system by 2045. This means designing, procuring, and processing medtech products in a way that maximises reuse, remanufacture, and recycling, thus preserving their value for as long as possible. The document sets out a plan of 30 actions to deliver the 2045 vision, which involve:

• driving positive behavioural change;
• exploring new commercial incentives to provide circular medtech, including value-based procurement;
• creating new standards to enable innovative products and services;
• planning the decontamination and recycling infrastructure of the future; and
• establishing new collaborations to accelerate the emergence of transformative science.

The Design for Life Roadmap is available at the following link:

https://www.gov.uk/government/publications/design-for-life-roadmap

As part of its work, the Design for Life programme maintains a list of products where circular alternatives are already available, and, for those with the highest potential benefits, explores means to accelerate adoption across the NHS. Ward curtains are on this product list, where a dedicated group, including procurement and clinical experts, are working to explore how the adoption of reusable versions can be supported.

With regards to trials, the Design for Life programme has commissioned several pilots within NHS trusts to explore safe transitions from single-use to reusables, where the results have been published and cascaded among the NHS community. Furthermore, NHS England has developed and deployed an Innovation Portal to help document, evaluate, test, and deploy innovations in waste management across the NHS in England.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that children referred for (a) neurodevelopmental and (b) paediatric assessment continue to receive care during transitions between (i) services and (ii) providers.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

It is the responsibility of the integrated care boards (ICBs) in England to make appropriate provision to meet the health and care needs of their local population, including pre-and-post diagnostic support for children with neurodevelopmental conditions, in line with relevant National Institute for Health and Care Excellence guidelines.

The 10-Year Health Plan commits to establishing a new radical approach that will ensure that, as children and young people navigate the National Health Service, they feel comfortable and confident in managing their own health and care from 16 years old where appropriate. This will include supporting young people as they move from child to adolescent and adult services, making sure that care is developmentally appropriate throughout.

A national transition framework is being developed to help local areas set up this model or to strengthen an existing one. The principles of age-appropriate services it will set out apply to young people receiving care for the first time as well as those already on a transition pathway.

While this framework focuses on the broad principles of transition, future work will focus on specific considerations and conditions. Training is also being developed for healthcare staff to develop their skills in providing the best standards of care.

In April 2023, NHS England published a framework and guidance to deliver improved outcomes in all-age autism assessment pathways. The guidance aims to help integrated care boards and the NHS to deliver improved outcomes for children, young people, and adults referred to an autism assessment service. This includes support for them and their families/carers, while they are waiting for a diagnostic assessment and once they have received the diagnostic outcome.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans make an assessment of the use of (a) fibrous forms of talc, (b) tremolite and (c) actinolite in products used by the NHS.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

From a medicines perspective, additives in medicines, termed excipients, are required to comply with the standards laid down in pharmacopeial monographs and can only be included in medicinal products at levels that are considered to be safe.

The Medicines and Healthcare products Regulatory Agency is aware of general concerns in relation to the presence of asbestos in talcum powder. However, pharmaceutical grade talc has strict controls on the presence of asbestos. The British Pharmacopeia monograph for Purified Talc states that “Talc derived from deposits that are known to contain associated asbestos is not suitable for pharmaceutical use”. Furthermore, testing is required to confirm the absence of asbestos.

NHS Supply Chain procurement activities require suppliers to comply with United Kingdom regulatory requirements such as the United Kingdom Accreditation Service or international equivalent accreditation for International Organization for Standardization (ISO) 9001 and ISO 13485, to ensure that products procured under NHS Supply Chain frameworks and used within the National Health Service in England are subject to rigorous safety assessments.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to bring forward a strategy for dental health research.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department invests over £1.6 billion each year on research through the National Institute for Health and Care Research (NIHR).

Whilst there are currently no plans to develop a dental health research strategy, the NIHR continues to welcome funding applications for research into any aspect of human health and care, including dental research. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.

The Department, through the NIHR, funds clinical academic training for doctors and dentists through the Integrated Academic Training Programme. This includes Academic Clinical Fellowships (ACFs) at the pre-doctoral level and Clinical Lectureships (CLs) at the post-doctoral level. Over the last five years, 91 ACFs and 24 CLs were recruited in dentistry.

The Department also funds the NIHR Oral Health Research Incubator, which is a researcher-led initiative aimed at building dental research capacity at the national level.

Ongoing research at Newcastle University is investigating the roles and skill utilisation of professionals in dental practice.

In addition, investments in NIHR infrastructure support the country’s leading experts to develop and deliver high-quality translational, clinical, and applied research that is funded by the NIHR’s research programmes, other public funders of research, charities, and the life sciences industry. For example, through the NIHR University College London Hospitals Biomedical Research Centre’s Oral and Dental Medicine research theme.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the impact of recent divestments made by the life sciences industry on local economies across England, including St Neots and Mid Cambridgeshire constituency.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

We do not hold specific data on the impact of recent divestments on local economies, including in St Neots and Mid Cambridgeshire, specifically.

We know this has been a challenging time for the life sciences sector, with commercial uncertainty and global competition driving recent divestment decisions. To address this, the Government has agreed a landmark trade deal with the United States which makes the United Kingdom the only country in the world to secure a zero percent tariff on pharmaceutical exports to the US, and preferential terms for medical technology exports. The Government is further securing the confidence of the pharmaceutical industry by committing to invest approximately 25% more in innovative, safe, and effective treatments, which will be the first major increase in over two decades.

We will continue to work with industry to deliver our Life Sciences Sector Plan, improve the commercial environment, and bring the benefits of a growing life sciences sector to local economies across the country.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 6 November 2025 to Question 83750 on Health Services: Innovation, what mechanisms are in place to monitor and evaluate the successful adoption and diffusion of health innovations across the NHS; which bodies are responsible for measuring this impact at (a) national and (b) regional levels; and how these findings inform future commissioning and policy decisions.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

No organisations hold a statutory responsibility specifically to monitor or evaluate the rates of the successful adoption and spread of health innovation in the National Health Service. However, the NHS Business Services Authority, on behalf of the Office for Life Sciences, publishes the Innovation Scorecard every six months. This is of significant use to the NHS and has been published since January 2013.

The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE). It reveals what NICE-recommended treatments are available at a local level within trusts and integrated care boards, as well as at national and NHS England region levels. Data limitations mean it cannot be used for performance management, but it does allow the NHS to identify variation, which, through discussion, can be explained, challenged, or acted upon.

Several organisations organise additional detailed evaluations for specific groups of health innovations. For example, the Health Innovation Network (HIN) oversees numerous national programmes which monitor the uptake and spread of selected health innovations. This helps them, and NHS England, determine how best to improve the uptake of these innovations.

Regionally, HINs also undertake monitoring and evaluation for selected innovations that they support. Integrated care boards and providers may also choose to conduct their own evaluations, using local data to understand whether innovations deliver expected improvements in outcomes or efficiency.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many deaths have been recorded in inpatient mental health settings in each of the last five years.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The information requested is not held centrally. All deaths of children and young people under the care of Tier 4 inpatient children and young people’s mental health services are routinely reported to the Department via NHS England. Such deaths are also notified to the Care Quality Commission and the National Confidential Inquiry into Suicide and Safety in Mental Health.

Since 2019, there have been a total of 23 deaths of young people aged under 18 years old in contact with Tier 4 services, including those on home leave, or who had absconded. We are unable to provide the information broken down by year, as the annual data held by NHS England includes a small patient count of fewer than five cases which could lead to the identification of individuals.

All providers are required to notify the Care Quality Commission of the deaths of patients detained under the Mental Health Act 1983. The following table shows the number of deaths of patients detained under the Mental Health Act notified to the Care Quality Commission in the last five years:

Source: the Care Quality Commission

Notes:

1. this data does not include deaths in mental health inpatient settings where the patient was not detained under the Mental Health Act; and
2. data for 2025 is up to 2 December 2025.

This data is counts of notifications to the Care Quality Commission under Regulation 17 of the Care Quality Commission (Registration) Regulations 2009, Notification of death or unauthorised absence of a service user who is detained or liable to be detained under the Mental Health Act 1983.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase research funding for bladder cancer.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Research is crucial in tackling cancer, which is why the Department invests £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR).

Between the 2020/21 and 2024/25 financial years, the NIHR committed £6 million for new research and programmes into bladder cancer research projects. An example of this investment includes a £2.9 million award for ‘Combination chemotherapy versus Bacillus Calmette-Guérin for high-risk non-muscle invasive bladder cancer a phase III multi-centre randomised controlled trial (COBRA)’. This study is researching whether gemcitabine and docetaxel delivered through intravesical therapy are typically recommended to patients who do not respond well to bacillus Calmette-Guerin treatment, a more common type of intravesical therapy that uses immunotherapy drugs to disrupt the processes that fuel bladder cancer growth.

The NIHR continues to welcome funding applications for research into any aspect of human health and care, including bladder cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to the public and health and care services, value for money, and scientific quality.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what information his Department holds on the amount the Exchequer has received from fines against NHS trusts since 2020.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Care Quality Commission (CQC) has criminal enforcement powers to fine a health or social care provider where they identify a breach of regulations. The CQC can directly serve a fixed penalty notice to a provider, or a fine may be issued by the court following prosecution brought by the CQC.

The size of the fine following prosecutions brought by the CQC is a decision made by the court and is informed by sentencing guidelines. The CQC does not have influence over this decision. The money raised by court fines is paid to HM Treasury. The following table shows the fines served by the court following prosecution brought by the CQC against National Health Service trusts since 2020:

Note: where an NHS trust is fined more than once in a given fiscal year, the fines relate to individual cases.

Any fixed penalty paid to the CQC is passed on by the CQC to My Rt Hon. Friend, the Secretary of State for Health and Social Care. The CQC transfers the penalties received to the Department on a quarterly basis. The following table shows the fixed penalty notices served by the CQC to NHS trusts since 2020:

Note: where an NHS Trust is served a fixed penalty notice more than once in a given fiscal year, this could be due to multiple breaches of regulations.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to leverage emerging technologies to combat falsified medicines and improve patient safety.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

No assessment of the impact of the disapplication of the EU Falsified Medicines Directive (EU FMD) on the United Kingdom’s medicine supply chain has been made by the Department. However, the Medicines and Healthcare products Regulatory Agency (MHRA) is not aware of any falsified medicines reaching patients through the legal supply chain in at least the last five years.

The MHRA leads work to combat falsified medicines and protect patient safety, including through the application of the Human Medicines Regulations 2012 to online and retail sales. The MHRA uses several different approaches to support its work to combat falsified medicines entering the UK supply chain, including by leveraging emerging technology, for instance:

• Its FakeMeds campaign guides the public on how to buy medicines online from safe and legitimate sources;
• suspected side effects or falsified medicines can be reported through the MHRA’s Yellow Card scheme;
• it is exploring the use of artificial intelligence to proactively identify illicit internet domains for enforcement action;
• it is working with Ofcom to use the new preventative powers provided by the Online Safety Act for regulating online platforms;
• it is developing an online service enabling users to check whether a website has been classified as ‘Not Recommended’; and
• it is developing a new web-based reporting tool to allow users to report suspicious online sellers directly to its Criminal Enforcement Unit.

Any additional initiatives to use emerging technologies, such as smartphone verification scanning, would require careful consideration of the evidence of the reduction of the risk to patients, as well as investment needed for infrastructure, and further regulatory changes for manufacturers and wholesalers. There are provisions in the Medicines and Medical Devices Act 2021 providing powers to enable the introduction of a similar system to the EU FMD with ‘safety features’ and verification in the UK. However, the powers allow us to go beyond the EU FMD and use derived data from any system for other health related purposes. For example, to support the recall of medicines, to support patient care, research, policy development, medicine supply, preventing diversion, supporting patient access to medicines, and countering fraud in primary care. However, regulations would be needed to set out the detail of any scheme, which would require consultation. Consideration is being given as to whether to consult on options for a potential UK system.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the disapplication of the EU Falsified Medicines Directive on the UK’s medicine supply chain.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

No assessment of the impact of the disapplication of the EU Falsified Medicines Directive (EU FMD) on the United Kingdom’s medicine supply chain has been made by the Department. However, the Medicines and Healthcare products Regulatory Agency (MHRA) is not aware of any falsified medicines reaching patients through the legal supply chain in at least the last five years.

The MHRA leads work to combat falsified medicines and protect patient safety, including through the application of the Human Medicines Regulations 2012 to online and retail sales. The MHRA uses several different approaches to support its work to combat falsified medicines entering the UK supply chain, including by leveraging emerging technology, for instance:

• Its FakeMeds campaign guides the public on how to buy medicines online from safe and legitimate sources;
• suspected side effects or falsified medicines can be reported through the MHRA’s Yellow Card scheme;
• it is exploring the use of artificial intelligence to proactively identify illicit internet domains for enforcement action;
• it is working with Ofcom to use the new preventative powers provided by the Online Safety Act for regulating online platforms;
• it is developing an online service enabling users to check whether a website has been classified as ‘Not Recommended’; and
• it is developing a new web-based reporting tool to allow users to report suspicious online sellers directly to its Criminal Enforcement Unit.

Any additional initiatives to use emerging technologies, such as smartphone verification scanning, would require careful consideration of the evidence of the reduction of the risk to patients, as well as investment needed for infrastructure, and further regulatory changes for manufacturers and wholesalers. There are provisions in the Medicines and Medical Devices Act 2021 providing powers to enable the introduction of a similar system to the EU FMD with ‘safety features’ and verification in the UK. However, the powers allow us to go beyond the EU FMD and use derived data from any system for other health related purposes. For example, to support the recall of medicines, to support patient care, research, policy development, medicine supply, preventing diversion, supporting patient access to medicines, and countering fraud in primary care. However, regulations would be needed to set out the detail of any scheme, which would require consultation. Consideration is being given as to whether to consult on options for a potential UK system.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the efficacy of smartphone-enabled barcode scanning in the verification of medicines.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

No assessment of the impact of the disapplication of the EU Falsified Medicines Directive (EU FMD) on the United Kingdom’s medicine supply chain has been made by the Department. However, the Medicines and Healthcare products Regulatory Agency (MHRA) is not aware of any falsified medicines reaching patients through the legal supply chain in at least the last five years.

The MHRA leads work to combat falsified medicines and protect patient safety, including through the application of the Human Medicines Regulations 2012 to online and retail sales. The MHRA uses several different approaches to support its work to combat falsified medicines entering the UK supply chain, including by leveraging emerging technology, for instance:

• Its FakeMeds campaign guides the public on how to buy medicines online from safe and legitimate sources;
• suspected side effects or falsified medicines can be reported through the MHRA’s Yellow Card scheme;
• it is exploring the use of artificial intelligence to proactively identify illicit internet domains for enforcement action;
• it is working with Ofcom to use the new preventative powers provided by the Online Safety Act for regulating online platforms;
• it is developing an online service enabling users to check whether a website has been classified as ‘Not Recommended’; and
• it is developing a new web-based reporting tool to allow users to report suspicious online sellers directly to its Criminal Enforcement Unit.

Any additional initiatives to use emerging technologies, such as smartphone verification scanning, would require careful consideration of the evidence of the reduction of the risk to patients, as well as investment needed for infrastructure, and further regulatory changes for manufacturers and wholesalers. There are provisions in the Medicines and Medical Devices Act 2021 providing powers to enable the introduction of a similar system to the EU FMD with ‘safety features’ and verification in the UK. However, the powers allow us to go beyond the EU FMD and use derived data from any system for other health related purposes. For example, to support the recall of medicines, to support patient care, research, policy development, medicine supply, preventing diversion, supporting patient access to medicines, and countering fraud in primary care. However, regulations would be needed to set out the detail of any scheme, which would require consultation. Consideration is being given as to whether to consult on options for a potential UK system.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what funding his department has allocated towards research into (a) Chron's and (b) Colitis in the last year.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department invests £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR).

In the financial year 2024/25, the NIHR committed £279,000 for new research projects and programmes into Crohn's and Colitis. The NIHR continues to welcome funding applications for research into any aspect of human health and care, including Crohn's and Colitis research.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of logistical challenges affecting rapid vaccine deployment in rural areas.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department, NHS England, and the UK Health Security Agency (UKHSA) work together to ensure a new vaccine is rolled out in a timely manner after a policy decision has been made, ensuring that all the components are in place to provide an accessible and safe programme. Supplies of centrally procured vaccines for the routine immunisation programme are available to order from UKHSA by all registered general practices, hospitals, maternity services, and other sites commissioned to deliver the programme. Sites have deliveries at least once a week, regardless of where in England they are located, and the coverage is across the country, including rural areas.

To improve public access to vaccinations, including in rural areas, we are expanding the use of community pharmacies giving vaccinations, including through delivering flu vaccines for two and three-year-olds this autumn. An evaluation will assess whether the use of community pharmacies improves coverage and helps tackle regional health inequalities, in line with the National Health Service vaccination strategy.

To ensure pharmacy access in rural areas, local authorities are required to undertake a pharmaceutical needs assessment every three years to assess whether their population is adequately served by local pharmacies and must keep these assessments under review.

We are also exploring ways of delivering our commitment to administer vaccinations as part of health visits. Local pathfinders for health visitor delivery will begin from January 2026, across a mix of urban and rural geographies.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department plans to increase the availability of defibrillators in (a) South Holland and the Deepings constituency and (b) Lincolnshire.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Over 110,000 defibrillators are registered in the United Kingdom on The Circuit, the independent automated external defibrillator (AED) database. The Department’s Community AED Fund delivered 3080 new AEDs to local communities between September 2023 and February 2025. The Department has no current plans to fund the purchase of additional AEDs, as local communities are best placed to make decisions about procuring, locating and maintaining AEDs.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many diagnoses have been made for diabetes so far in 2025.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The information requested is available from the National Diabetes Audit which provides a count of the number of people with a general practice record of diabetes. The latest published data from the audit for April 2024 to March 2025 is available at the following link:

https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/core-q4-24-25/national-diabetes-audit-nda-2024-25-quarterly-report-for-england-integrated-care-board-icb-primary-care-network-pcn-and-gp-practice

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he is taking steps to provide long-term funding arrangements for the Nursery Milk Scheme and the School Milk Subsidy Scheme to ensure continuity of provision for early years and primary education settings.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Nursery Milk Scheme is operated by the Department of Health and Social Care and provides reimbursement to early years childcare settings to cover the cost of providing one-third of a pint of milk per day to all children under the age of five years old who attend the setting for more than two hours per day. The School Milk Subsidy Scheme is the responsibility of the Department for Environment Food and Rural Affairs and partly finances the cost of similar milk provision to children in primary and secondary schools in England and Wales. There are no current plans to change these schemes.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will list the organisations his Department has consulted on its upcoming acquired brain injury action plan.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

I attended the UK Acquired Brain Injury Forum’s (UKABIF’s) annual summit in Manchester on 3 November 2025, where I discussed our forthcoming acquired brain injury (ABI) plan with a number of stakeholders, patients with lived experience and healthcare professionals with a specialist interest in ABI.

The Government’s ABI action plan will be published in the first half of 2026. It will be a landmark step in delivering the joined-up approach that people with ABI deserve.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when his Department intends to publish the acquired brain injury action plan.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

I attended the UK Acquired Brain Injury Forum’s (UKABIF’s) annual summit in Manchester on 3 November 2025, where I discussed our forthcoming acquired brain injury (ABI) plan with a number of stakeholders, patients with lived experience and healthcare professionals with a specialist interest in ABI.

The Government’s ABI action plan will be published in the first half of 2026. It will be a landmark step in delivering the joined-up approach that people with ABI deserve.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate has been made of the total number of food hygiene officers in English local government for each year from 2010 to date.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Local authorities must ensure they perform official controls on all food businesses regularly, on a risk basis and with appropriate frequency. The Food Law Code of Practice provides these food hygiene intervention frequencies with a higher risk and/or non-compliant will receive an intervention more frequently than those compliant or lower risk.

Data pertaining to the average time between food hygiene visits undertaken for hot food takeaway venues in England is not held by the Food Standards Agency (FSA) as we do not categorise food establishment in that way. This data could be gathered individually from local authorities.

Data reported to the FSA on the number of authorised food hygiene officers in England by local authorities via their returns data is as follows:

- 1,178 authorised officers were in post at the end of 2021/22;

- 1,605 authorised officers were in post at the end of 2022/23;

- 1,797 authorised officers were in post at the end of 2023/24; and

- 1,828 authorised officers were in post at the end of 2024/25.

This information does not include regulatory support officers or trainees working towards suitable qualifications. Prior to 2021/22 only questions relating to full time equivalent posts were requested from local authorities in relation to their resources.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what the current average time is between food hygiene visits undertaken for hot food takeaway venues in England.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Local authorities must ensure they perform official controls on all food businesses regularly, on a risk basis and with appropriate frequency. The Food Law Code of Practice provides these food hygiene intervention frequencies with a higher risk and/or non-compliant will receive an intervention more frequently than those compliant or lower risk.

Data pertaining to the average time between food hygiene visits undertaken for hot food takeaway venues in England is not held by the Food Standards Agency (FSA) as we do not categorise food establishment in that way. This data could be gathered individually from local authorities.

Data reported to the FSA on the number of authorised food hygiene officers in England by local authorities via their returns data is as follows:

- 1,178 authorised officers were in post at the end of 2021/22;

- 1,605 authorised officers were in post at the end of 2022/23;

- 1,797 authorised officers were in post at the end of 2023/24; and

- 1,828 authorised officers were in post at the end of 2024/25.

This information does not include regulatory support officers or trainees working towards suitable qualifications. Prior to 2021/22 only questions relating to full time equivalent posts were requested from local authorities in relation to their resources.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve integration between NHS services and social care provision in Lincolnshire.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Department is committed to improving integration between health and social care services nationally and locally. Our vision for neighbourhood health will see local government and the National Health Service working more closely together, with a revitalised role of Health and Wellbeing Boards and reform of the Better Care Fund (BCF).

Through the BCF, approximately £9 billion is being invested in 2025/26 to enable NHS bodies and local authorities to pool budgets and deliver joined-up care. This includes setting shared goals to reduce delayed discharges, avoid unnecessary hospital admissions, and support people to live independently at home.

In Lincolnshire, local Health and Wellbeing Boards are required to agree plans under the BCF framework to provide timely and coordinated support for people with complex needs. These plans prioritise effective discharge from hospital and recovery in the community.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many patients have received checks under the NHS Targeted Lung Health Check and NHS Lung Cancer Screening Programme per month in each of the last three years.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The National Health Service is currently rolling out the National Lung Cancer Screening Programme to people with a history of smoking. The following table shows the number of participants who attended an appointment through the NHS Lung Cancer Screening Programme each month, between April 2022 and September 2025:

Source: the NHS England Lung Cancer Screening Programme.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that Government funding for public health is not use to promote disinformation about vaccines.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

National Health Service bodies and upper tier and unitary local authorities in England are responsible for making effective, appropriate use of the resources allocated to them, including funding for public health. Local authorities receive a Public Health Grant from the Department, totalling £3.884 billion in 2025/26. This grant, other than funding allocated to Greater Manchester authorities via their retained business rate arrangement, is ring-fenced for use on public health functions, and the local authority Director of Public Health must certify annually that the funding has been used for appropriate purposes. NHS England commissions national NHS public health services, including national immunisation programmes. It does so to evidence-based standards and is accountable for performance to the Department.

The Government is focused on combating vaccine misinformation as part of its 10-Year Health Plan, working with local authorities and community groups to support vaccine trust.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the (a) treatment and (b) prevention of cardiovascular diseases that disproportionately impact women, including (i) Spontaneous Coronary Artery Dissection, (ii) Myocardial Infarction with Non-Obstructive Coronary Arteries and (iii) Takotsubo Cardiomyopathy.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

In 2023, 31% of those who died prematurely from cardiovascular disease (CVD) were women. We are committed to reducing premature mortality from heart disease and stroke by 25% in the next 10 years through improvements in prevention and treatment.

To accelerate progress towards this ambition, we will publish a new cardiovascular disease Modern Service Framework (CVD MSF) in 2026. The CVD MSF will support consistent, high quality and equitable care whilst fostering innovation across the CVD pathway.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many people are currently being treated for Mesothelioma.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The latest data for England from Cancer Waiting Times shows that for the month of September 2025 the number of people that started first or subsequent treatment for Mesothelioma after a decision to treat was 168, and the number of people that started their first treatment for Mesothelioma following referral was 107.

We have now launched our first Men’s Health Strategy which includes targeted support to address health inequalities in ex-mining and industrial communities, who often face persistent respiratory and cardiovascular disease burdens. We will expand the existing Respiratory Pathways Transformation Fund initiative by investing an additional £1 million to develop targeted case-finding initiatives in former coalfield areas to help us to identify the individuals who need support to access appropriate local services.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve recruitment and retention of general practitioners in Bristol North East.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

Since October 2024 we have funded primary care networks with an additional £160 million to recruit recently qualified general practitioners (GPs) through the Additional Roles Reimbursement Scheme (ARRS). In the Bristol, North Somerset and South Gloucestershire Integrated Care Board (ICB) 44 GPs have been recruited via the scheme since October 2024.

Within the 2025/26 GP Contract, a number of changes have been confirmed to increase the flexibility of ARRS and allow primary care networks to respond better to local workforce needs. This includes GPs and practice nurses included in the main ARRS funding pot, an uplift of the maximum reimbursable rate for GPs in the scheme, and no caps on the number of GPs that can be employed through the scheme.

We are investing an additional £1.1 billion into GPs to reinforce the front door of the National Health Service, bringing total spend on the GP Contract to £13.4 billion in 2025/26. This is the biggest cash increase in over a decade and will facilitate the recruitment of GPs. The 8.9% boost to the GP Contract in 2025/26 is greater than the 5.8% growth to the NHS budget as a whole.

The Bristol, North Somerset and South Gloucestershire ICB also has a successful GP and Nurse fellowship scheme to support retention of staff.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate has been made of the number of recorded incidents of (a) verbal abuse (b) physical assault (c) sexual assault and (d) harassment against staff in (i) GP practices (ii) pharmacies (iii) dentists in England.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Department does not hold data on the number of recorded incidents in these settings, which are each independent contractors to the National Health Service.

We know how challenging disgraceful incidences of abuse and violence can be for staff. The Government is clear that there is never a justification for this unacceptable behaviour towards healthcare staff, who have the right to work free from fear of abuse or assault.

There is a range of NHS commissioned services available to support the mental health and wellbeing of staff across settings.

Incidents of criminal behaviour should be reported to the police. In May 2025, the Crown Prosecution Service updated guidance to prosecutors which will bring swifter justice against those that assault our frontline workers.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the value for money of management and service charges paid by GP surgeries to related parties in England.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

General practice surgeries are independent contractors, and as private businesses it is within their own remit to consider the value for money of management and service charges paid to related parties in England.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the (a) availability and (b) levels of use of tan-enhancing products containing Melanotan II is being considered in the development of the forthcoming cancer plan.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Government is taking steps to prevent, diagnose, and treat cancers more quickly, including skin cancers. The forthcoming National Cancer Plan will cover the entirety of the cancer pathway from referral and diagnosis to treatment and ongoing care. It will set out how we will improve outcomes for cancer patients, including by speeding up diagnosis and treatment, ensuring patients have access to the latest treatments and technology, and ultimately driving up this country’s cancer survival rates. We will publish the National Cancer Plan in the new year to reduce the number of lives lost to cancer over the next 10 years.

We received over 11,000 responses to our call for evidence from individuals, professionals, and organisations, and we are reviewing the submissions from skin cancer partners. While no formal assessment has been made of the availability and levels of use of tan-enhancing products containing Melanotan II, respondents shared concerns about tanning products and their potential links to cancer, particularly melanoma. Our expansive engagement will allow the National Cancer Plan to have patients at its heart.

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the regulation of medicinal products and medical devices in the United Kingdom. Although tanning is not considered to be a medical purpose, injectable products containing Melanotan I or Melanotan II have been determined as medicinal products due to their similarity to the authorised medicine Scenesse.

In relation to nasal sprays containing Melanotan I or Melanotan II, there are no equivalent authorised medicines and in the absence of medicinal claims, they are not regarded as medicinal products.

Medicinal products must hold a relevant Marketing Authorisation to be legally sold and supplied in the UK. This also guarantees that the medicines have been tested for conformity with strict standards of quality, safety, and efficacy.

The MHRA takes action when a medicinal product without appropriate authorisations is identified.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce variations in the approaches of commissioners in meeting local population need for palliative and end of life care services.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Government is developing a Palliative Care and End of Life Care Modern Service Framework (MSF) for England. I refer the hon. Member to the Written Ministerial Statement HCWS1087 I gave to the House on 24 November 2025.

Through our MSF, we will closely monitor the shift towards strategic commissioning of palliative care and end of life care services to ensure that services reduce variation in access to, and quality of, palliative and end of life care services at local and regional levels.

This is further made clear in the recently published Strategic Commissioning Framework and Medium Term Planning Guidance, which make clear the expectations that integrated care boards should understand current and projected total service utilisation and costs for those at the end of life, creating an overall plan to more effectively meet these needs through neighbourhood health.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce regional inequalities in (a) access to and (b) quality of palliative and end of life care.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

The Government is developing a Palliative Care and End of Life Care Modern Service Framework (MSF) for England. I refer the hon. Member to the Written Ministerial Statement HCWS1087 I gave to the House on 24 November 2025.

Through our MSF, we will closely monitor the shift towards strategic commissioning of palliative care and end of life care services to ensure that services reduce variation in access to, and quality of, palliative and end of life care services at local and regional levels.

This is further made clear in the recently published Strategic Commissioning Framework and Medium Term Planning Guidance, which make clear the expectations that integrated care boards should understand current and projected total service utilisation and costs for those at the end of life, creating an overall plan to more effectively meet these needs through neighbourhood health.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that patients have timely access to innovative cancer medicines.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

In England, the National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS based on an assessment of clinical and cost effectiveness. The NHS is legally required to fund NICE recommended medicines, normally within three months of final guidance, and cancer medicines are eligible for funding from the point of a positive draft NICE recommendation. NICE aims wherever possible to issue guidance on new medicines close to the time of licensing to ensure that patients are able to benefit from rapid access to clinically and cost effective new medicines.

The Life Sciences Sector Plan sets out the measures we are taking that will mean that patients are able to access medicines three to six months faster, including improved alignment between the Medicines and Healthcare products Regulatory Agency’s decisions and NICE guidance publication.

In England in 2024/25, 93% of NICE recommendations for cancer treatments were positive. Positive includes recommended, optimised, recommended in the cancer drugs fund (CDF), and optimised in the CDF.

Health is a devolved matter and as such it would not be appropriate for me to comment on access to medicines within the devolved administrations.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the publication Updating labelling guidance for no and low-alcohol alternatives, published on 28 September 2023, and pursuant to the Answer of 31 March 2025, to Question 41063, on Low Alcohol Drinks: Labelling and Marketing, whether the Government intends to publish a response to the 2023 consultation.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

In Fit for the Future: 10-Year Health Plan for England, the Government has committed to exploring whether to raise the upper alcohol limit for drinks labelled as alcohol-free to 0.5% alcohol by volume (ABV) from 0.05% ABV, as set out in the current labelling guidance for no and low (NoLo) alcohol drink alternatives.

Department officials are progressing work to take forward this commitment, and we will update stakeholders in due course. The consultation referred to was undertaken by the previous administration. A decision on publishing a response will be made as part of determining the delivery timescales of the NoLo commitments in the 10-Year Health Plan.

Found: Samantha Jones OBE Permanent Secretary Department of Health and Social Care 39 Victoria

Found: developed by the National Infrastructure and Service Transformation Authority (NISTA) – supported by DHSC

Found: Department for Health and Social Care relating to recommendations of the Committee’s Twenty-fifth Report on DHSC

Found: Letter from the Permanent Secretary at the Department for Health and Social Care relating to the DHSC-NHSE

Found: on establishing the digital centre of government • Nesil Caliskan: Spending of the Department of Health and Social Care

Found: expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care

Found: with digital technology suppliers HC 640 26th Tackling Violence against Women and Girls HC 644 25th DHSC

Found: requirement on all marketing authorisation holders to inform the Department for Health and Social Care (DHSC

Found: Cross-departmental Workforce Strategy and Specialist Workforce The Department is working closely with DHSC

Found: requirement on all marketing authorisation holders to inform the Department for Health and Social Care (DHSC

Found: Department of Health and Social Care (DHSC), and Department of Health and Social Care (DHSC) Oral Evidence

Found: The Department of Health and Social Care (and forerunners) received the highest proportion of WPQs both

Found: Will it come from within the existing Department of Health and Social Care budget?

Found: with digital technology suppliers HC 640 26th Tackling Violence against Women and Girls HC 644 25th DHSC

Found: ● Policy coherence: Aligning ODA, trade and foreign policy across FCDO, DHSC, Treasury, and Cabinet

Found:  The Department for Education and Department of Health and Social Care should scale up investment

Found: of government departments and ministries—for example, the Ministry of Defence, the Department of Health and Social Care

Found: We are also working very closely with other Government Departments such as DHSC, as they roll out their

Found: DHSC/NHS England and DfE will continue to monitor expansion rates and support Integrated Care Boards

Found: have talked about in this Committee before, we have work going on jointly with the Department of Health and Social Care

Found: Letter from the Chief Executive of NHS England relating to the Committee’s Twenty-fifth Report on DHSC

Found: 2025, Govt must stop multi-million pound campaign promoting meat and dairy: Open letter to DEFRA, DHSC

Found: that and the £86 billion is the biggest R&D budgets that are held by other Departments, namely MoD, DHSC

Found: There is further to go with the DHSC, the Department for Education and the Department for Work and

Question to the Department for Education:

To ask the Secretary of State for Education, if she will establish a cross-government protocol with the Home Office and the Department of Health and Social Care setting out roles, referral routes and timescales between schools, police forces and health services when responding to allegations of child-on-child sexual abuse.

Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)

This government is taking the strongest action to tackle child sexual abuse and exploitation. This includes setting up a new national inquiry, with which government departments will cooperate fully, to ensure we are tackling this vile crime and supporting victims and survivors.

Working Together is the national multi-agency statutory guidance for all practitioners working with children and their families. Local safeguarding partners (local authorities, police and health) already have a statutory duty to set out in their threshold document and local protocols the process for referrals, assessments, support and services for children who need help or protection. This guidance underpins Ofsted’s Inspection of Local Authority Children’s Services framework.

We are also delivering the biggest reform to children’s social care in a generation, investing £2.4 billion in the Families First Partnership programme, introducing multi-agency child protection teams through our landmark Children's Wellbeing and Schools Bill and establishing a national Child Protection Authority.

Question to the Department for Education:

To ask the Secretary of State for Education, what steps she is taking to improve (a) universal, (b) targeted and (c) specialist speech, language and communication support for children in schools.

Answered by Georgia Gould - Minister of State (Education)

The department is working closely with the Department of Health and Social Care and NHS England to improve access to community health services, including speech and language therapy, for children and young people with special educational needs and disabilities. This includes extending the Early Language Support for Every Child programme, trialling new ways of working to better identify and support children with speech, language and communication needs in early years settings and primary schools.

We are also continuing to grow the pipeline. In addition to the undergraduate degree route, speech and language therapists can also train via a degree apprenticeship. This route is now in its fourth year of delivery and offers an alternative pathway to the traditional degree route into a successful career as a speech and language therapist.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what steps she is taking to promote research into treatments for glioblastoma.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

The Department for Science, Innovation and Technology invests approximately £200 million annually in cancer research via UK Research and Innovation (UKRI), and the Department of Health and Social Care (DHSC) spent £141.6 million in 2024/25 via the National Institute for Health and Care Research (NIHR). The Government does not ringfence funding for specific cancers, but is committed to advancing brain tumour research, including glioblastoma. In recent years, NIHR directly invested £11.8 million and UKRI invested £46.8 million into brain tumour research. This included two new glioblastoma research projects funded by the Medical Research Council in 2023.

Question to the Department for Education:

To ask the Secretary of State for Education, what consideration her Department has given to including milk in government-funded breakfast clubs without reducing funding for existing milk provision schemes.

Answered by Olivia Bailey - Parliamentary Under-Secretary of State (Department for Education) (Equalities)

The department funds schools taking part in the free breakfast clubs programme to buy breakfast foods and drinks, as well as to cover staffing and delivery costs.

Schools are required to provide a breakfast adhering to the school food standards, which could include a glass of lower fat milk. However, it is up to schools to decide what they serve in line with the standards. Where schools provide milk, they can also choose whether to participate in the national school milk subsidy scheme which can be used to reduce the cost of the milk

Additionally, the Nursery Milk Scheme is operated and funded by the Department of Health and Social Care and provides free milk to children under five at participating schools and childcare settings.

Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to support research teams undertaking long-term cancer prevention and early-detection research.

Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)

The Department for Science, Innovation and Technology invests approximately £200 million annually in cancer research via UK Research and Innovation (UKRI), and the Department of Health and Social Care (DHSC) spent £141.6 million in 2024/25 via the National Institute for Health and Care Research (NIHR). The Office for Life Science’s Cancer Healthcare Goal Programme has invested over £16 million to support development of early detection innovations, such as multi cancer detection tests. DHSC will be publishing a National Cancer Plan for England in the new year. This will set out the Government’s long-term strategy to improve outcomes for cancer patients, including prevention and early-detection R&D.

Question to the Department for Education:

To ask the Secretary of State for Education, what steps her Department is taking to help ensure that specialist speech and language therapies are available to children with education, health and care plans in Surrey Heath constituency.

Answered by Georgia Gould - Minister of State (Education)

The department is working closely with the Department of Health and Social Care and NHS England to improve access to community health services, including speech and language therapy, for children and young people with special educational needs and disabilities. This includes extending the Early Language Support for Every Child programme, trialling new ways of working to better identify and support children with speech, language and communication needs in early years settings and primary schools.

In addition to the undergraduate degree route, speech and language therapists can also train via a degree apprenticeship. This route is now in its fourth year of delivery and offers an alternative pathway to the traditional degree route into a successful career as a speech and language therapist, helping to grow the pipeline.

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what steps his Department is taking to support people with mental health illnesses into work in (a) Surrey and (b) Surrey Heath constituency.

Answered by Diana Johnson - Minister of State (Department for Work and Pensions)

Good work is generally good for health and wellbeing, so we want everyone to get work and get on in work, whoever they are and wherever they live. Backed by £240 million investment, the Get Britain Working White Paper launched in November 2024 is driving forward approaches to tackling economic inactivity and supporting people into work.

Disabled people and people with health conditions, including people with mental health conditions, are a diverse group so access to the right work and health support, in the right place, at the right time, is key. We therefore have a range of specialist initiatives to support individuals to stay in work and get back into work including those that join up employment and health systems.

In Surrey, Work Coaches refer customers to Talking Therapies via the Healthy Surrey website, ensuring timely access to professional mental health support. Additionally, DWP has strong relationships with We Are With You (Talking Therapies), particularly through Woking Jobcentre Plus (JCP) and other Surrey sites, enabling seamless referrals.

Our Youth Hub in Surrey Heath plays a key role in supporting young people with mental health needs. Mental health services such as Mind Matters, Social Prescribing, and WorkWell feed into the hub, ensuring young people can access wraparound support for wellbeing alongside employment advice. WorkWell has a twice-weekly presence at Guildford JCP, offering mental health and employment support.

Connect to Work is opening across all of England and Wales throughout 2025 and early 2026 and the Surrey Connect to Work delivery area is open for referrals. This new voluntary, locally commissioned Supported Employment programme is suitable for individuals with mental health conditions to find and stay in work. Participants are given a dedicated specialist employment support adviser who works alongside them to understand their career goals and help them to address any specific barriers to employment. The employment adviser works with both the employer and the participant to ensure that the transition into work is smooth and that the workplace is inclusive.

Other measures to support people with mental health conditions into work include support from Disability Employment Advisers in Jobcentres and Access to Work grants.

Our Health Work Coaches provide personalised support, including Pathways to Work and Additional Work Coach Time (AWCT) interventions, ensuring individuals receive consistent and empathetic guidance. The GP Outreach and GP Integrated Mental Health Service intersect many mental health referrals, providing holistic support and signposting.

In recognition of employers’ vital role in addressing health-related economic activity, we appointed Sir Charlie Mayfield to lead the Keep Britain Working independent review, which was published on 5 November. In partnership with DBT and DHSC we are launching Vanguards to test new employer-led approaches to support individuals to stay in work, putting his key recommendations into action from day one. In the review, Sir Charlie recommended that mental health in young people should be a priority area for the Vanguards to explore.

The 10 Year Health Plan, published in July, builds on existing work to better integrate health with employment support and incentivise greater cross-system collaboration, recognising good work is good for health. The Plan also states the Government’s intention to break down barriers to opportunity by delivering the holistic support that people need to access and thrive in employment by ensuring a better health service for everyone, regardless of condition or service area. It outlines how the neighbourhood health service will join up support from across the work, health and skills systems to help address the multiple complex challenges that often stop people finding and staying in work.

Question to the Cabinet Office:

To ask the Minister for the Cabinet Office, what formal guidance, policies and risk assessments he has issued to research institutions, NHS bodies and private genomics companies on the sharing of genomic data with foreign entities.

Answered by Dan Jarvis - Minister of State (Cabinet Office)

The 2023 UK Biological Security Strategy (BSS) sets out how the country is strengthening resilience to a spectrum of biological threats. As part of the BSS, DSIT is ensuring the UK is a world leader in responsible innovation in engineering biology – working closely with academia and industry to improve shared awareness of security risks, and ensuring any measures to mitigate risks (including those related to genomic data) remain proportionate.

All organisations holding health data (including genomics data) must comply with GDPR. To comply with GDPR, DSIT and DHSC require safeguards to be in place when health data is transferred outside the UK, including a risk assessment for countries not recognised as offering an equivalent level of data protection by the UK.

On behalf of DSIT, the National Protective Security Authority (NPSA), with the National Cyber Security Centre (NCSC), have developed the Trusted Research campaign to advise academia on international collaborations, by informing them of the threat and helping them make decisions about research and research partners. NPSA and NCSC have also developed the Secure Innovation campaign to help new start-ups in the emerging and critical technology sectors think carefully about their partners and investment.

Alongside this work, DSIT’s Research Collaboration Advice Team offers the research sector tailored advice on managing the risks of international research collaboration. DSIT also engages in a two-way dialogue with policymakers, academia and industry on the responsible use of engineering biology and life sciences, through the Responsible Innovation Advisory Panel.

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what steps he is taking to support people living with mental health conditions and on benefits into the workplace.

Answered by Diana Johnson - Minister of State (Department for Work and Pensions)

Good work is generally good for health and wellbeing, so we want everyone to get work and get on in work, whoever they are and wherever they live. Backed by £240 million investment, the Get Britain Working White Paper launched in November 2024 is driving forward approaches to tackling economic inactivity.

Disabled people and people with health conditions, including people with mental health conditions, are a diverse group so access to the right work and health support, in the right place, at the right time, is key. We therefore have a range of specialist initiatives to support individuals to stay in work and get back into work including those that join up employment and health systems. Existing measures include support from Work Coaches and Disability Employment Advisers in Jobcentres and Access to Work grants, as well as joining up health and employment support around the individual through Employment Advisors in NHS Talking Therapies and WorkWell. We are also rolling out Connect to Work, our supported employment programme for anyone who is disabled, and has a health condition or is experiencing more complex barriers to work.

In recognition of employer’s vital role in addressing health-related economic activity we appointed Sir Charlie Mayfield to lead the Keep Britain Working independent review, which was published on 5 November. In partnership with DBT and DHSC colleagues we are immediately launching Vanguards to test new employer-led approaches to support individuals to stay in work, putting his key recommendations into action from day one. In the review, Sir Charlie has recommended that mental health in young people should be a priority area as a deep dive for the Vanguards.

The NHS 10 Year Health Plan, published in July, stated the Government’s intention to break down barriers to opportunity by delivering the holistic support that people need to access and thrive in employment by ensuring a better health service for everyone, regardless of condition or service area. It outlines how the neighbourhood health service will join up support from across the work, health and skills systems to help address the multiple complex challenges that often stop people finding and staying in work.

Question to the Department for Education:

To ask the Secretary of State for Education, what measures are being undertaken to recruit speech and language therapists.

Answered by Georgia Gould - Minister of State (Education)

The department is working closely with the Department of Health and Social Care and NHS England to improve access to community health services, including speech and language therapy, for children and young people with special educational needs and disabilities. This includes extending the Early Language and Support for Every Child programme, trialling new ways of working to better identify and support children with Speech, Language and Communication Needs in early years settings and primary schools.

In addition to the undergraduate degree route, speech and language therapists can also train via a degree apprenticeship. This route is now in its fourth year of delivery and offers an alternative pathway to the traditional degree route into a successful career as a speech and language therapist.

Found: Explanatory notes and an impact assessment have been provided by the Department of Health and Social Care

Horton Cemetery

Found:  Plan Pharmaceuticals, medical technologies (medtech) DBT , Department of Health & Social Care (DHSC

Found: Financial audit Date: 11 Dec 2025 Topics: Health and social care Departments: Department of Health and Social Care

Found: Security and Net Zero 10 Department for Environment, Food and Rural Affairs 11 Department of Health and Social Care

Found: farm-business-income/farm- business-income-by-type-of-farm-in-england-202324 Department for Health and Social Care (DHSC

Found: adult social care notional allocations will be set out in the Department of Health and Social Care’s (DHSC

Found: Introduction The Department of Health and Social Care (DHSC) and the Ministry of Housing, Communities

Found: The Department for Health and Social Care (DHSC) will continue to the pay the consolidated PH Grant

Found: The MoJ are working with the Department of Health and Social Care, NHS England (NHSE), the Welsh Government

Found: the first 1% of pay awards by maximising value from existing budgets2, whilst the Department of Health and Social Care

Found: Government, Home Office, Department for Education, Department for Work and Pensions, Department of Health and Social Care

Found: (DHSC, with MHCLG) • Work with councils and Integrated Care Boards to improve how existing funding

Found: - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Q3 2025 Department of Health and Social Care

Found: class="govuk-table__cell">Q3 2025

Found: Transport [note 4] 963 938 0 25 94 Department for Work and Pensions 1091 1074 0 17 2 Department of Health and Social Care

Found: Other funding from the Ministry of Housing, Communities and Local Government Department of Health and Social Care

Found: govuk-template--rebranded" lang="en">